Epidemiology, pathophysiology, and treatment of Barrett's esophagus: reducing mortality from esophageal adenocarcinoma
- 1 March 2005
- journal article
- review article
- Published by Elsevier in Medical Clinics of North America
- Vol. 89 (2) , 293-312
Abstract
No abstract availableKeywords
This publication has 111 references indexed in Scilit:
- Endoscopic screening and surveillance for Barrett's esophagus: Can claims data determine its effectiveness?Gastrointestinal Endoscopy, 2003
- Detection of high-grade dysplasia in Barrett's esophagus by spectroscopy measurement of 5-aminolevulinic acid-induced protoporphyrin IX fluorescenceGastrointestinal Endoscopy, 2002
- The Effect of Selective Cyclooxygenase-2 Inhibition in Barrett's Esophagus Epithelium: An In Vitro StudyJNCI: Journal of the National Cancer Institute, 2002
- Preoperative chemotherapy unmasks underlying Barrett’s mucosa in patients with adenocarcinoma of the distal esophagusSurgical Endoscopy, 2002
- Ethnicity and gender of patients with suspected Barrett's esophagus in a large endoscopy cohort (CORI)Gastrointestinal Endoscopy, 2001
- Regression of columnar‐lined (Barrett’s) oesophagus with omeprazole 40 mg daily: results of 5 years of continuous therapyAlimentary Pharmacology & Therapeutics, 1999
- Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazoleGastrointestinal Endoscopy, 1996
- Detection by scanning electron microscopy of a distinctive esophageal surface cell at the junction of squamous and Barrett's epitheliumDigestive Diseases and Sciences, 1993
- Adenocarcinomas arising in tongues or short segments of Barrett's esophagusDigestive Diseases and Sciences, 1992
- Symptomatic gastroesophageal reflux: Incidence and precipitating factorsDigestive Diseases and Sciences, 1976